Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

A novel mutation of ROBO3 in horizontal gaze palsy with progressive scoliosis.

Bozdoğan ST, Dinç E, Ayça Sarı A, Özgür A, Bişgin A.

Ophthalmic Genet. 2016 Jun 7:1-2. [Epub ahead of print] No abstract available.

PMID:
27267957
2.

Radiation and SN38 treatments modulate the expression of microRNAs, cytokines and chemokines in colon cancer cells in a p53-directed manner.

Pathak S, Meng WJ, Nandy SK, Ping J, Bisgin A, Helmfors L, Waldmann P, Sun XF.

Oncotarget. 2015 Dec 29;6(42):44758-80. doi: 10.18632/oncotarget.5815.

3.
4.

What is your diagnosis?

Çetin C, Büyükkurt S, Özbarlas N, Bişgin A, Özgünen FT.

J Turk Ger Gynecol Assoc. 2015 Jun 1;16(2):121-2. doi: 10.5152/jtgga.2015.15195. eCollection 2015. No abstract available.

5.

Serum soluble tumour necrosis factor related apoptosis-inducing ligand level and peripheral eosinophil count in patients with nasal polyposis.

Bisgin A, Eyigor H, Osma U, Yilmaz MD, Yalcin AD.

J Laryngol Otol. 2015 Mar;129(3):250-3. doi: 10.1017/S0022215114003442. Epub 2015 Feb 6.

PMID:
25655059
6.

Level of TNF-related apoptosis-inducing-ligand and CXCL8 correlated with 2-[18F]Fluoro-2-deoxy-D-glucose uptake in anti-VEGF treated colon cancers.

Celik B, Yalcin AD, Bisgin A, Dimitrakopoulou-Strauss A, Kargi A, Strauss LG.

Med Sci Monit. 2013 Oct 21;19:875-82. doi: 10.12659/MSM.889605.

7.

Increased serum S-TRAIL level in newly diagnosed stage-IV lung adenocarcinoma but not squamous cell carcinoma is correlated with age and smoking.

Kargi A, Bisgin A, Yalcin AD, Kargi AB, Sahin E, Gumuslu S.

Asian Pac J Cancer Prev. 2013;14(8):4819-22.

8.

Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels.

Yalcin AD, Cilli A, Bisgin A, Strauss LG, Herth F.

Expert Opin Biol Ther. 2013 Sep;13(9):1335-41. doi: 10.1517/14712598.2013.819338. Epub 2013 Jul 24.

PMID:
23883435
9.
10.

Clinical course and side effects of anti-IgE monoclonal antibody in patients with severe persistent asthma.

Yalcin AD, Bisgin A, Cetinkaya R, Yildirim M, Gorczynski RM.

Clin Lab. 2013;59(1-2):71-7.

PMID:
23505909
11.
12.

IL-8, IL-10, TGF-β, and GCSF levels were increased in severe persistent allergic asthma patients with the anti-IgE treatment.

Yalcin AD, Bisgin A, Gorczynski RM.

Mediators Inflamm. 2012;2012:720976. doi: 10.1155/2012/720976. Epub 2012 Dec 19.

13.

Trimetazidine effect on burn-induced intestinal mucosal injury and kidney damage in rats.

Yalcin AD, Bisgin A, Erbay RH, Oguz O, Demir S, Yilmaz M, Gumuslu S.

Int J Burns Trauma. 2012;2(2):110-7. Epub 2012 Sep 15.

14.
15.

The relation of sTRAIL levels and quality of life in severe persistent allergic asthma patients using omalizumab.

Yalcin AD, Bisgin A.

Med Sci Monit. 2012 Aug;18(8):LE9-10. No abstract available.

PMID:
22847211
16.

Jessner lymphocytic infiltrate as a side effect of bee venom immunotherapy.

Yalcin AD, Bisgin A, Akman A, Erdogan G, Ciftcioglu MA, Yegin O.

J Investig Allergol Clin Immunol. 2012;22(4):308-9. No abstract available.

17.

Systemic levels of ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis.

Yalcin AD, Gumuslu S, Parlak GE, Bisgin A, Yildiz M, Kargi A, Gorczynski RM.

Immunopharmacol Immunotoxicol. 2012 Dec;34(6):1047-53. doi: 10.3109/08923973.2012.697902. Epub 2012 Jun 28.

PMID:
22737977
18.

Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients.

Bisgin A, Yalcin AD, Gorczynski RM.

Diabetes Res Clin Pract. 2012 Jun;96(3):e84-6. doi: 10.1016/j.diabres.2012.02.028. Epub 2012 Mar 23.

PMID:
22446096
19.
20.
Items per page

Supplemental Content

Loading ...
Write to the Help Desk